Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software & TMT
Energy & Infrastructure
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
US
INT
DA
DE
FR
SV
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
All
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
All
14 Nov 2024
Equity Research GIAB, Q3 2024: Positive EBIT is encouraging
Equity Research
12 Nov 2024
Equity Research ALM Equity, Q3 2024: Nearly debt-free in October
Equity Research
ALM Equity
08 Nov 2024
Equity Research Nosa Plugs: First impression Q3, 2024
Equity Research
Nosa Plugs
04 Nov 2024
Equity Research InCoax, Q3 2024: Nokia's global marketing positive for InCoax
Equity Research
InCoax
01 Nov 2024
Equity Research InCoax, Q3 2024: Higher revenues, but also higher costs than expected
Equity Research
InCoax
31 Oct 2024
Equity Research Enrad, Q3 2024: Strong focus on increased production capacity
Equity Research
Enrad
31 Oct 2024
Equity research CDON: A new platform to build marketplace excellence
Equity Research
CDON
25 Oct 2024
Equity research Teneo AI, Q3 2024: Excellent growth driven by increased volumes
Equity Research
Teneo AI
25 Oct 2024
Equity Research Enrad, Q3 2024: Sales in line with expectations, but better than expected gross margin
Equity Research
Enrad
21 Oct 2024
Carlsquare Equity Research: Real Estate Equity Snapshot
Equity Research
ALM Equity
21 Oct 2024
Equity research, Viva Wine Group: We expect solid performance in a slow market in Q3 2024
Equity Research
Viva Wine Group
09 Oct 2024
Carlsquare Weekly Market Letter: Christmas has come early for stock traders this year
Equity Research
04 Oct 2024
Equity research, Zinzino: On track to achieve growth target
Equity Research
Zinzino
02 Oct 2024
Carlsquare weekly market letter: China took the lead – what’s next?
Equity Research
Carlsquare
25 Sep 2024
Carlsquare weekly market letter: Is China finally taking off?
Equity Research
Carlsquare
23 Sep 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
18 Sep 2024
Carlsquare weekly market letter: Another leg down – or time for small caps?
Equity Research
Carlsquare
16 Sep 2024
Carlsquare Equity Research: Swedish consumer sector snapshot
Equity Research
Viva Wine Group
12 Sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research
Biosergen
11 Sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Equity Research
Carlsquare
1
…
9
10
11
12
13
…
63